These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25380209)

  • 1. [Perspectives on the pharmacotherapy of diseases extending with advanced oxidation protein products participation].
    Piwowar A
    Postepy Hig Med Dosw (Online); 2014 Nov; 68():1264-75. PubMed ID: 25380209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The advanced oxidation protein products as potential diagnostic and prognostic factor in diseases of the indicated participation of oxidative stress].
    Piwowar A
    Postepy Hig Med Dosw (Online); 2014 May; 68():446-58. PubMed ID: 24864097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis.
    Zhou LL; Cao W; Xie C; Tian J; Zhou Z; Zhou Q; Zhu P; Li A; Liu Y; Miyata T; Hou FF; Nie J
    Kidney Int; 2012 Oct; 82(7):759-70. PubMed ID: 22622498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway.
    Wu Q; Zhong ZM; Zhu SY; Liao CR; Pan Y; Zeng JH; Zheng S; Ding RT; Lin QS; Ye Q; Ye WB; Li W; Chen JT
    Apoptosis; 2016 Jan; 21(1):36-50. PubMed ID: 26520447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.
    Ou H; Huang Z; Mo Z; Xiao J
    Cardiovasc Toxicol; 2017 Jan; 17(1):1-12. PubMed ID: 27350146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical and clinical aspects of advanced oxidation protein products in kidney diseases and metabolic disturbances].
    Piwowar A
    Postepy Hig Med Dosw (Online); 2014 Feb; 68():179-90. PubMed ID: 24662786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury.
    Yamamoto Y; Yamamoto H
    Kidney Int; 2012 Oct; 82(7):733-5. PubMed ID: 22975994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of soluble RAGE, AGEs and AOPPs at the early stage of amyotrophic lateral sclerosis: A preliminary study.
    Juranek J; Osowski A; Wojtkiewicz J; Banach M
    Polim Med; 2023; 53(2):105-110. PubMed ID: 38112253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products.
    Zhang SS; Wu Z; Zhang Z; Xiong ZY; Chen H; Huang QB
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1413-1419. PubMed ID: 27965099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-products and advanced oxidation protein products in schizophrenia.
    Pandolfo G; Genovese G; Bruno A; Campolo D; Tigano V; Cristani M; Casciaro M; Pioggia G; Gangemi S
    Psychiatry Res; 2022 May; 311():114527. PubMed ID: 35344686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced oxidation protein products induce catabolic effect through oxidant-dependent activation of NF-κ B pathway in human chondrocyte.
    Ye W; Zhong Z; Zhu S; Zheng S; Xiao J; Song S; Yu H; Wu Q; Lin Z; Chen J
    Int Immunopharmacol; 2016 Oct; 39():149-157. PubMed ID: 27475664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of advanced oxidation protein products on the proliferation and osteogenic differentiation of rat mesenchymal stem cells.
    Sun N; Yang L; Li Y; Zhang H; Chen H; Liu D; Li Q; Cai D
    Int J Mol Med; 2013 Aug; 32(2):485-91. PubMed ID: 23722883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Antiglycoxidative Ability of Selected Phenolic Compounds-An In Vitro Study.
    Piwowar A; Rorbach-Dolata A; Fecka I
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31344905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia.
    Ding R; Jiang H; Sun B; Wu X; Li W; Zhu S; Liao C; Zhong Z; Chen J
    Redox Biol; 2016 Dec; 10():1-11. PubMed ID: 27665186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway.
    Zhang Z; Yang L; Lei L; Chen R; Chen H; Zhang H
    Int J Mol Med; 2016 Oct; 38(4):1161-9. PubMed ID: 27574116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Oxidation of Collagen Promotes the Formation of Advanced Oxidation Protein Products and the Activation of Human Neutrophils.
    Bochi GV; Torbitz VD; de Campos LP; Sangoi MB; Fernandes NF; Gomes P; Moretto MB; Barbisan F; da Cruz IB; Moresco RN
    Inflammation; 2016 Apr; 39(2):916-27. PubMed ID: 26920846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.
    Di Lorenzo G; Minciullo PL; Leto-Barone MS; La Piana S; La Porta G; Saija A; Gangemi S
    J Investig Allergol Clin Immunol; 2013; 23(2):101-6. PubMed ID: 23654076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.
    Anwar S; Khan S; Almatroudi A; Khan AA; Alsahli MA; Almatroodi SA; Rahmani AH
    Mol Biol Rep; 2021 Jan; 48(1):787-805. PubMed ID: 33389535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced oxidation protein products induce endothelial-to-mesenchymal transition in human renal glomerular endothelial cells through induction of endoplasmic reticulum stress.
    Liang X; Duan N; Wang Y; Shu S; Xiang X; Guo T; Yang L; Zhang S; Tang X; Zhang J
    J Diabetes Complications; 2016; 30(4):573-9. PubMed ID: 26861949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced oxidation protein products and their relationship with cardiovascular risk factors in young apparently healthy people.
    Villalpando Sánchez DC; Alvarez Aguilar C; Gómez García A
    Clin Investig Arterioscler; 2017; 29(5):209-215. PubMed ID: 28619393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.